Ikarian Capital’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.71M | Sell |
1,000,221
-25,000
| -2% | -$67.8K | 0.52% | 32 |
|
|
2025
Q1 | $3.48M | Sell |
1,025,221
-101,416
| -9% | -$344K | 0.43% | 32 |
|
|
2024
Q4 | $4.64M | Buy |
+1,126,637
| New | +$4.64M | 0.63% | 22 |
|
|
2023
Q3 | – | Sell |
-221,830
| Closed | -$304K | – | 99 |
|
|
2023
Q2 | $304K | Hold |
221,830
| – | – | 0.05% | 65 |
|
|
2023
Q1 | $524K | Hold |
221,830
| – | – | 0.12% | 69 |
|
|
2022
Q4 | $515K | Hold |
221,830
| – | – | 0.12% | 42 |
|
|
2022
Q3 | $612K | Sell |
221,830
-140,707
| -39% | -$388K | 0.12% | 43 |
|
|
2022
Q2 | $884K | Hold |
362,537
| – | – | 0.16% | 50 |
|
|
2022
Q1 | $1.43M | Buy |
362,537
+17,959
| +5% | +$70.8K | 0.19% | 55 |
|
|
2021
Q4 | $1.52M | Hold |
344,578
| – | – | 0.23% | 53 |
|
|
2021
Q3 | $2.13M | Sell |
344,578
-5,422
| -2% | -$33.5K | 0.15% | 65 |
|
|
2021
Q2 | $2.77M | Buy |
350,000
+100,000
| +40% | +$791K | 0.22% | 62 |
|
|
2021
Q1 | $2.68M | Buy |
+250,000
| New | +$2.68M | 0.09% | 87 |
|